Heron Overcomes Two CRLs To Win Zynrelef Approval In Post-Op Pain

 
• By Joseph Haas

The combination of bupivacaine and meloxicam will be priced at a discount to Exparel, with Heron predicting rapid uptake. Label limited to three surgery types, but analysts expect off-label use.

FDA Approved typed words on a vintage typewriter
After two CRLs, Heron obtains US approval of its combo therapy for post-surgical pain

More from New Products

More from Scrip